PFIZER LAUNCHES A PHASE III CLINICAL TRIAL FOR A NEW LYME DISEASE VACCINE

Mya Care13 Jan, 2023Health

The need for vaccination against Lyme disease is steadily increasing as the disease is becoming widespread. According to a recent analysis, Lyme disease diagnosis in the U.S. increased by 375% in rural areas and 65% in urban areas from 2007 to 2021. he Lyme vaccine, VLA15, was developed by Valneva in collaboration with Pfizer. More Info :